Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women

Martinez DR1, Fong Y2, Li SH3, Yang F4, Jennewein MF5, Weiner JA6, Harrell EA4, Mangold JF3, Goswami R3, Seage GR 3rd7, Alter G5, Ackerman ME6, Peng X8, Fouda GG9, Permar SR10.

  1. Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  2. Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  3. Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  4. Department of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC 27607, USA.
  5. Ragon Institute of the Massachusetts General Hospital, MIT and Harvard, Cambridge, MA 02139, USA.
  6. Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
  7. Department of Epidemiology, Harvard T.H. School of Public Health, Boston, MA 02115, USA.
  8. Department of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC 27607, USA; Bioinformatics Graduate Program, North Carolina State University, Raleigh, NC 27607, USA; Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27607, USA.
  9. Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: genevieve.fouda@duke.edu.
  10. Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: sallie.permar@duke.edu.

Presented by David R Martinez